{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T16:57:22Z","timestamp":1789059442052,"version":"build-2803163510"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2021,11,10]],"date-time":"2021-11-10T00:00:00Z","timestamp":1636502400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,11,10]],"date-time":"2021-11-10T00:00:00Z","timestamp":1636502400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Bone Miner Metab"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1007\/s00774-021-01279-2","type":"journal-article","created":{"date-parts":[[2021,11,10]],"date-time":"2021-11-10T13:10:19Z","timestamp":1636549819000},"page":"292-300","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Skeletal effects of combined bisphosphonates treatment and parathyroidectomy in osteoporotic patients with primary hyperparathyroidism"],"prefix":"10.1007","volume":"40","author":[{"given":"Hun Jee","family":"Choe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo Kyung","family":"Koo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ka Hee","family":"Yi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sung Hye","family":"Kong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jung Hee","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chan Soo","family":"Shin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jee Won","family":"Chai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9561-9110","authenticated-orcid":false,"given":"Sang Wan","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,11,10]]},"reference":[{"key":"1279_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00198-016-3716-2","volume":"28","author":"AA Khan","year":"2017","unstructured":"Khan AA, Hanley DA, Rizzoli R, Bollerslev J, Young JE et al (2017) Primary hyperparathyroidism: review and recommendations on evaluation, diagnosis, and management. A Canadian and international consensus. Osteoporos Int 28:1\u201319. https:\/\/doi.org\/10.1007\/s00198-016-3716-2","journal-title":"Osteoporos Int"},{"key":"1279_CR2","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1038\/nrendo.2017.104","volume":"14","author":"MD Walker","year":"2018","unstructured":"Walker MD, Silverberg SJ (2018) Primary hyperparathyroidism. Nat Rev Endocrinol 14:115\u2013125. https:\/\/doi.org\/10.1038\/nrendo.2017.104","journal-title":"Nat Rev Endocrinol"},{"key":"1279_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1365-2265.2007.03162.x","volume":"69","author":"L Mosekilde","year":"2008","unstructured":"Mosekilde L (2008) Primary hyperparathyroidism and the skeleton. Clin Endocrinol (Oxf) 69:1\u201319. https:\/\/doi.org\/10.1111\/j.1365-2265.2007.03162.x","journal-title":"Clin Endocrinol (Oxf)"},{"key":"1279_CR4","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1046\/j.0954-6820.2003.01237.x","volume":"255","author":"P Vestergaard","year":"2004","unstructured":"Vestergaard P, Mosekilde L (2004) Parathyroid surgery is associated with a decreased risk of hip and upper arm fractures in primary hyperparathyroidism: a controlled cohort study. J Intern Med 255:108\u2013114. https:\/\/doi.org\/10.1046\/j.0954-6820.2003.01237.x","journal-title":"J Intern Med"},{"key":"1279_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.jocd.2020.12.005","author":"R Khan","year":"2020","unstructured":"Khan R, Martin J, Das G (2020) The impact of observation versus parathyroidectomy on bone mineral density and fracture risk determined by FRAX tool in patients with primary hyperparathyroidism. J Clin Densitom. https:\/\/doi.org\/10.1016\/j.jocd.2020.12.005","journal-title":"J Clin Densitom"},{"key":"1279_CR6","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1136\/bmj.321.7261.598","volume":"321","author":"P Vestergaard","year":"2000","unstructured":"Vestergaard P, Mollerup CL, Frokjaer VG, Christiansen P, Blichert-Toft M, Mosekilde L (2000) Cohort study of risk of fracture before and after surgery for primary hyperparathyroidism. BMJ 321:598\u2013602. https:\/\/doi.org\/10.1136\/bmj.321.7261.598","journal-title":"BMJ"},{"key":"1279_CR7","doi-asserted-by":"publisher","first-page":"3607","DOI":"10.1210\/jc.2014-1417","volume":"99","author":"C Marcocci","year":"2014","unstructured":"Marcocci C, Bollerslev J, Khan AA, Shoback DM (2014) Medical management of primary hyperparathyroidism: proceedings of the fourth international workshop on the management of asymptomatic primary hyperparathyroidism. J Clin Endocrinol Metab 99:3607\u20133618. https:\/\/doi.org\/10.1210\/jc.2014-1417","journal-title":"J Clin Endocrinol Metab"},{"key":"1279_CR8","doi-asserted-by":"publisher","first-page":"79","DOI":"10.3389\/fendo.2017.00079","volume":"8","author":"JS Leere","year":"2017","unstructured":"Leere JS, Karmisholt J, Robaczyk M, Vestergaard P (2017) Contemporary medical management of primary hyperparathyroidism: a systematic review. Front Endocrinol (Lausanne) 8:79. https:\/\/doi.org\/10.3389\/fendo.2017.00079","journal-title":"Front Endocrinol (Lausanne)"},{"key":"1279_CR9","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1007\/s12020-011-9459-0","volume":"39","author":"A Faggiano","year":"2011","unstructured":"Faggiano A, Di Somma C, Ramundo V, Severino R, Vuolo L, Coppola A, Panico F, Savastano S, Lombardi G, Colao A, Gasperi M (2011) Cinacalcet hydrochloride in combination with alendronate normalizes hypercalcemia and improves bone mineral density in patients with primary hyperparathyroidism. Endocrine 39:283\u2013287. https:\/\/doi.org\/10.1007\/s12020-011-9459-0","journal-title":"Endocrine"},{"key":"1279_CR10","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1097\/SLA.0b013e31824c5252","volume":"255","author":"XM Keutgen","year":"2012","unstructured":"Keutgen XM, Buitrago D, Filicori F, Kundel A, Elemento O, Fahey TJ 3rd, Zarnegar R (2012) Calcimimetics versus parathyroidectomy for treatment of primary hyperparathyroidism: retrospective chart analysis of a prospective database. Ann Surg 255:981\u2013985. https:\/\/doi.org\/10.1097\/SLA.0b013e31824c5252","journal-title":"Ann Surg"},{"key":"1279_CR11","doi-asserted-by":"publisher","first-page":"655","DOI":"10.3275\/7970","volume":"35","author":"F Cetani","year":"2012","unstructured":"Cetani F, Saponaro F, Banti C, Cianferotti L, Vignali E, Chiavistelli S, Viccica G, Pinchera A, Marcocci C (2012) Cinacalcet efficacy in patients with moderately severe primary hyperparathyroidism according to the European Medicine Agency prescription labeling. J Endocrinol Invest 35:655\u2013660. https:\/\/doi.org\/10.3275\/7970","journal-title":"J Endocrinol Invest"},{"key":"1279_CR12","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/S2213-8587(20)30063-2","volume":"8","author":"JS Leere","year":"2020","unstructured":"Leere JS, Karmisholt J, Robaczyk M, Lykkeboe S, Handberg A, Steinkohl E, Frokjaer JB, Vestergaard P (2020) Denosumab and cinacalcet for primary hyperparathyroidism (DENOCINA): a randomised, double-blind, placebo-controlled, phase 3 trial. Lancet Diabetes Endocrinol 8:407\u2013417. https:\/\/doi.org\/10.1016\/S2213-8587(20)30063-2","journal-title":"Lancet Diabetes Endocrinol"},{"key":"1279_CR13","doi-asserted-by":"publisher","first-page":"715","DOI":"10.7326\/M15-1232","volume":"164","author":"MW Yeh","year":"2016","unstructured":"Yeh MW, Zhou H, Adams AL, Ituarte PH, Li N, Liu IL, Haigh PI (2016) The relationship of parathyroidectomy and bisphosphonates with fracture risk in primary hyperparathyroidism: an observational study. Ann Intern Med 164:715\u2013723. https:\/\/doi.org\/10.7326\/M15-1232","journal-title":"Ann Intern Med"},{"key":"1279_CR14","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1055\/a-0850-8679","volume":"51","author":"GA Miguel","year":"2019","unstructured":"Miguel GA, Carranza FH, Rodriguez JCR, Ramos MA, Pablos DL, Herrero EF, Diaz-Guerra GM (2019) Trabecular Bone Score, bone mineral density and bone markers in patients with primary hyperparathyroidism 2 years after parathyroidectomy. Horm Metab Res 51:186\u2013190. https:\/\/doi.org\/10.1055\/a-0850-8679","journal-title":"Horm Metab Res"},{"key":"1279_CR15","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1016\/s8756-3282(99)00207-0","volume":"25","author":"P Christiansen","year":"1999","unstructured":"Christiansen P, Steiniche T, Brixen K, Hessov I, Melsen F, Heickendorff L, Mosekilde L (1999) Primary hyperparathyroidism: effect of parathyroidectomy on regional bone mineral density in Danish patients: a three-year follow-up study. Bone 25:589\u2013595. https:\/\/doi.org\/10.1016\/s8756-3282(99)00207-0","journal-title":"Bone"},{"key":"1279_CR16","doi-asserted-by":"publisher","first-page":"1901","DOI":"10.1210\/jcem.85.5.6604","volume":"85","author":"D Nakaoka","year":"2000","unstructured":"Nakaoka D, Sugimoto T, Kobayashi T, Yamaguchi T, Kobayashi A, Chihara K (2000) Prediction of bone mass change after parathyroidectomy in patients with primary hyperparathyroidism. J Clin Endocrinol Metab 85:1901\u20131907. https:\/\/doi.org\/10.1210\/jcem.85.5.6604","journal-title":"J Clin Endocrinol Metab"},{"key":"1279_CR17","doi-asserted-by":"publisher","first-page":"3395","DOI":"10.1007\/s00198-016-3715-3","volume":"27","author":"N Singh Ospina","year":"2016","unstructured":"Singh Ospina N, Maraka S, Rodriguez-Gutierrez R, Espinosa de Ycaza AE, Jasim S, Gionfriddo M, Castaneda-Guarderas A, Brito JP, Al Nofal A, Erwin P, Wermers R, Montori V (2016) Comparative efficacy of parathyroidectomy and active surveillance in patients with mild primary hyperparathyroidism: a systematic review and meta-analysis. Osteoporos Int 27:3395\u20133407. https:\/\/doi.org\/10.1007\/s00198-016-3715-3","journal-title":"Osteoporos Int"},{"key":"1279_CR18","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1210\/jcem.80.3.7883824","volume":"80","author":"SJ Silverberg","year":"1995","unstructured":"Silverberg SJ, Gartenberg F, Jacobs TP, Shane E, Siris E, Staron RB, McMahon DJ, Bilezikian JP (1995) Increased bone mineral density after parathyroidectomy in primary hyperparathyroidism. J Clin Endocrinol Metab 80:729\u2013734. https:\/\/doi.org\/10.1210\/jcem.80.3.7883824","journal-title":"J Clin Endocrinol Metab"},{"key":"1279_CR19","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/s8756-3282(99)00150-7","volume":"25","author":"P Christiansen","year":"1999","unstructured":"Christiansen P, Steiniche T, Brixen K, Hessov I, Melsen F, Heickendorff L, Mosekilde L (1999) Primary hyperparathyroidism: short-term changes in bone remodeling and bone mineral density following parathyroidectomy. Bone 25:237\u2013244. https:\/\/doi.org\/10.1016\/s8756-3282(99)00150-7","journal-title":"Bone"},{"key":"1279_CR20","doi-asserted-by":"publisher","first-page":"4007","DOI":"10.1210\/jcem.81.11.8923852","volume":"81","author":"SJ Silverberg","year":"1996","unstructured":"Silverberg SJ, Locker FG, Bilezikian JP (1996) Vertebral osteopenia: a new indication for surgery in primary hyperparathyroidism. J Clin Endocrinol Metab 81:4007\u20134012. https:\/\/doi.org\/10.1210\/jcem.81.11.8923852","journal-title":"J Clin Endocrinol Metab"},{"key":"1279_CR21","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1007\/s00223-015-9971-y","volume":"97","author":"Y Bala","year":"2015","unstructured":"Bala Y, Seeman E (2015) Bone\u2019s material constituents and their contribution to bone strength in health, disease, and treatment. Calcif Tissue Int 97:308\u2013326. https:\/\/doi.org\/10.1007\/s00223-015-9971-y","journal-title":"Calcif Tissue Int"},{"key":"1279_CR22","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1038\/s41584-019-0172-3","volume":"15","author":"E Seeman","year":"2019","unstructured":"Seeman E, Martin TJ (2019) Antiresorptive and anabolic agents in the prevention and reversal of bone fragility. Nat Rev Rheumatol 15:225\u2013236. https:\/\/doi.org\/10.1038\/s41584-019-0172-3","journal-title":"Nat Rev Rheumatol"},{"key":"1279_CR23","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1038\/ki.2008.242","volume":"74","author":"A Yajima","year":"2008","unstructured":"Yajima A, Inaba M, Tominaga Y, Ito A (2008) Bone formation by minimodeling is more active than remodeling after parathyroidectomy. Kidney Int 74:775\u2013781. https:\/\/doi.org\/10.1038\/ki.2008.242","journal-title":"Kidney Int"},{"key":"1279_CR24","first-page":"53","volume":"1","author":"JA Gasser","year":"2000","unstructured":"Gasser JA, Kneissel M, Thomsen JS, Mosekilde L (2000) PTH and interactions with bisphosphonates. J Musculoskelet Neuronal Interact 1:53\u201356","journal-title":"J Musculoskelet Neuronal Interact"},{"key":"1279_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.bone.2021.115850","volume":"145","author":"PR Jensen","year":"2021","unstructured":"Jensen PR, Andersen TL, Chavassieux P, Roux JP, Delaisse JM (2021) Bisphosphonates impair the onset of bone formation at remodeling sites. Bone 145:115850. https:\/\/doi.org\/10.1016\/j.bone.2021.115850","journal-title":"Bone"},{"key":"1279_CR26","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1055\/s-0033-1349842","volume":"45","author":"J Szymczak","year":"2013","unstructured":"Szymczak J, Bohdanowicz-Pawlak A (2013) Osteoprotegerin, RANKL, and bone turnover in primary hyperparathyroidism: the effect of parathyroidectomy and treatment with alendronate. Horm Metab Res 45:759\u2013764. https:\/\/doi.org\/10.1055\/s-0033-1349842","journal-title":"Horm Metab Res"},{"key":"1279_CR27","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1007\/s12020-020-02401-6","volume":"69","author":"D Miyaoka","year":"2020","unstructured":"Miyaoka D, Imanishi Y, Kato E, Toi N, Nagata Y, Kurajoh M, Yamada S, Inaba M, Emoto M (2020) Effects of denosumab as compared with parathyroidectomy regarding calcium, renal, and bone involvement in osteoporotic patients with primary hyperparathyroidism. Endocrine 69:642\u2013649. https:\/\/doi.org\/10.1007\/s12020-020-02401-6","journal-title":"Endocrine"},{"key":"1279_CR28","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1001\/jama.285.6.785","volume":"285","author":"NIH Consensus Development Panel on Osteoporosis Prevention D, Therapy","year":"2001","unstructured":"NIH Consensus Development Panel on Osteoporosis Prevention D, Therapy (2001) Osteoporosis prevention, diagnosis, and therapy. JAMA 285:785\u2013795. https:\/\/doi.org\/10.1001\/jama.285.6.785","journal-title":"JAMA"},{"key":"1279_CR29","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1210\/jc.2017-01932","volume":"103","author":"NE Cusano","year":"2018","unstructured":"Cusano NE, Rubin MR, Silva BC, Tay YD, Williams JM, Agarwal S, Omeragic B, Guo XE, Bilezikian JP (2018) Skeletal microstructure and estimated bone strength improve following parathyroidectomy in primary hyperparathyroidism. J Clin Endocrinol Metab 103:196\u2013205. https:\/\/doi.org\/10.1210\/jc.2017-01932","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Journal of Bone and Mineral Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00774-021-01279-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00774-021-01279-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00774-021-01279-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,9]],"date-time":"2022-03-09T04:05:17Z","timestamp":1646798717000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00774-021-01279-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,10]]},"references-count":29,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,3]]}},"alternative-id":["1279"],"URL":"https:\/\/doi.org\/10.1007\/s00774-021-01279-2","relation":{},"ISSN":["0914-8779","1435-5604"],"issn-type":[{"value":"0914-8779","type":"print"},{"value":"1435-5604","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,10]]},"assertion":[{"value":"21 May 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 October 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 November 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}